Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CANCER,NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00981578
What this trial is testing

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Who this might be right for
Bone Metastases
InSightec 37
Not applicableStudy completedNCT02065726
What this trial is testing

Whey Protein Supplementation in Cancer Patients

Who this might be right for
Solid Tumors
Fondazione IRCCS Policlinico San Matteo di Pavia 166
Testing effectiveness (Phase 2)Study completedNCT00055978
What this trial is testing

Celecoxib in Preventing Lung Cancer in Former Heavy Smokers

Who this might be right for
Lung Cancer
University of California, Los Angeles 112
Not applicableStudy completedNCT01706185
What this trial is testing

Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer

Who this might be right for
Neoplasms, Urinary Bladder
GlaxoSmithKline 156
Not applicableStudy completedNCT00792285
What this trial is testing

RCT of Automated Telephone Outreach to Improve Colorectal Cancer Screening

Who this might be right for
Colorectal Cancer
Harvard Pilgrim Health Care 80,000
Testing effectiveness (Phase 2)Looking for participantsNCT07309185
What this trial is testing

Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy

Who this might be right for
Stomach Neoplasms
Shandong Tumor Hospital 66
Not applicableStudy completedNCT07827885
What this trial is testing

20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Fondazione Policlinico Universitario Campus Bio-Medico 80
Not applicableUnknownNCT03709485
What this trial is testing

Evaluation of Gut Microbiome in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ziv Hospital 150
Testing effectiveness (Phase 2)Looking for participantsNCT06780085
What this trial is testing

Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 96
Not applicableActive Not RecruitingNCT04001543
What this trial is testing

Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 27
Not applicableLooking for participantsNCT07527143
What this trial is testing

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
Mayo Clinic 25
Large-scale testing (Phase 3)Study completedNCT00212615
What this trial is testing

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
C04.588.274.476.411.307
Odense University Hospital 116
Testing effectiveness (Phase 2)Looking for participantsNCT06567015
What this trial is testing

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Pierre Fabre Medicament 171
Testing effectiveness (Phase 2)Study completedNCT00020735
What this trial is testing

Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Joel Nelson, MD 45
Testing effectiveness (Phase 2)Study completedNCT03565835
What this trial is testing

Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Montefiore Medical Center 31
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Not applicableEnded earlyNCT03885908
What this trial is testing

Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center 20
Not applicableNot Yet RecruitingNCT07691008
What this trial is testing

Wearable Data for Personalized Prognostication in Cancer: A Registry Protocol

Who this might be right for
Hematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm+1 more
City of Hope Medical Center 1,200
Testing effectiveness (Phase 2)Study completedNCT00890825
What this trial is testing

AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 88
Not applicableUnknownNCT06041464
What this trial is testing

Study of HLA-DR in Cell Cultures Isolated From Primary Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckCancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 4
Next Page